Total Funding
30
52
Total FundingDebt Financing raised
Growth Score
-2 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
118345
Meru Biotechnologies develops a compensated backscattering interferometry solution for understanding and measuring molecular binding.
- Dan Rodenhaver: CEO
- Theresa Schaub: Co-Founder and CCO
About the Company
Meru Biotechnologies develops a compensated backscattering interferometry solution for understanding and measuring molecular binding. The Compensated Back Scattering Interferometry (CBSI) is a label-free and free solution assay technology for measuring molecular interaction. The study of proteins often involves immobilization, labeling,
fractionation, and removal from the native environment depriving them of substances needed to function properly. CBSI quantifies the interaction of molecules in solution without labeling, immobilization, tethering, or special impedance plates.
The company was founded in 2019 and is headquartered in Richmond, Virginia.
Women Founded
